Zangerle John Adam 4
4 · STERIS plc · Filed Jun 17, 2025
Insider Transaction Report
Form 4
STERIS plcSTE
Zangerle John Adam
Sr. VP, Gen Counsel, and Sec.
Transactions
- Sale
Ordinary Shares
2025-06-13$241.61/sh−1,648$398,173→ 33,760 total - Sale
Ordinary Shares
2025-06-13$240.63/sh−330$79,408→ 35,408 total
Footnotes (3)
- [F1]Price reflects a weighted average sale price for multiple transactions ranging from $240.20 to $241.17 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- [F2]As of June 13, 2025, 8,713 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 202 on October 1, 2025; 1,157 on June 1, 2026; 846 on June 2, 2026; 1,252 on June 3, 2026; 1,376 on June 4, 2026; 1,252 on June 3 2027; 1,376 on June 4, 2027 and 1,252 on June 5, 2028.
- [F3]Price reflects a weighted average sale price for multiple transactions ranging from $241.28 to $241.815 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.